SCHEMBL4765079

SCHEMBL4765079

CCCCOC(=O)Nc1ncc(C(N[S+]([O-])C(C)(C)C)c2ccc(Cl)cc2F)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.41
RAB9A P51151 5/20 0.38
NPC1 O15118 4/20 0.38
ALDH1A1 P00352 4/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
NFKB1 P19838 1/20 0.38
STAT1 P42224 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
TSHR P16473 2/20 0.36
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2A1 P68400 1/20 0.35
GAA P10253 2/20 0.34
HPGD P15428 3/20 0.34
CYP2C9 P11712 1/20 0.34
P2RY2 P41231 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1923732 0.87 S1PR3 (0.39) P2RY2FFAR2
SCHEMBL1690967 0.87 S1PR3 (0.39) P2RY2FFAR2
SCHEMBL10125038 0.87 S1PR3 (0.39) P2RY2FFAR2
SCHEMBL1924081 0.87 S1PR3 (0.39) P2RY2FFAR2
SCHEMBL1690804 0.87 S1PR3 (0.39) P2RY2FFAR2
SCHEMBL16678081 0.85 FFAR2 (0.38) SMN1; SMN2RAB9ANFKB1NFKB2RELA
SCHEMBL12377971 0.85 FFAR2 (0.35) FFAR2
SCHEMBL14145310 0.76 S1PR3 (0.37) P2RY2FFAR2
SCHEMBL1690761 0.75 KCNH2 (0.32)
SCHEMBL1690755 0.75 KCNH2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912983-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals, Inc. (US) 2008-04-23 EP disclosed
WO-2007021982-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-02-22 WO disclosed